Fusion Antibodies PLC
LSE:FAB

Watchlist Manager

Fusion Antibodies PLC

LSE:FAB

Watchlist

Dividends

Price: 6.35 GBX -3.79%

Market Cap: 7.2m GBX

Have any thoughts about
Fusion Antibodies PLC?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 6.35 GBX

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

FAB Alert

Fusion Antibodies PLC

6.35

-0.25 (-3.79%)

52 Week Range	2.9 10.2
Price Target

We'll email you a reminder when the closing price reaches GBX.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Fusion Antibodies PLC

What unique competitive advantages
does Fusion Antibodies PLC hold over its rivals?

What risks and challenges
does Fusion Antibodies PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Fusion Antibodies PLC.

What unique competitive advantages
does Fusion Antibodies PLC hold over its rivals?

What risks and challenges
does Fusion Antibodies PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fusion Antibodies PLC.

Provide P/S
for Fusion Antibodies PLC.

Provide P/E
for Fusion Antibodies PLC.

Provide P/OCF
for Fusion Antibodies PLC.

Provide P/FCFE
for Fusion Antibodies PLC.

Provide P/B
for Fusion Antibodies PLC.

Provide EV/S
for Fusion Antibodies PLC.

Provide EV/GP
for Fusion Antibodies PLC.

Provide EV/EBITDA
for Fusion Antibodies PLC.

Provide EV/EBIT
for Fusion Antibodies PLC.

Provide EV/OCF
for Fusion Antibodies PLC.

Provide EV/FCFF
for Fusion Antibodies PLC.

Provide EV/IC
for Fusion Antibodies PLC.

What are the Revenue projections
for Fusion Antibodies PLC?

How accurate were the past Revenue estimates
for Fusion Antibodies PLC?

What are the Net Income projections
for Fusion Antibodies PLC?

How accurate were the past Net Income estimates
for Fusion Antibodies PLC?

What are the EPS projections
for Fusion Antibodies PLC?

How accurate were the past EPS estimates
for Fusion Antibodies PLC?

What are the EBIT projections
for Fusion Antibodies PLC?

How accurate were the past EBIT estimates
for Fusion Antibodies PLC?

Compare the revenue forecasts
for Fusion Antibodies PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fusion Antibodies PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fusion Antibodies PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fusion Antibodies PLC compared to its peers.

Compare the P/E ratios
of Fusion Antibodies PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Fusion Antibodies PLC with its peers.

Analyze the financial leverage
of Fusion Antibodies PLC compared to its main competitors.

Show all profitability ratios
for Fusion Antibodies PLC.

Provide ROE
for Fusion Antibodies PLC.

Provide ROA
for Fusion Antibodies PLC.

Provide ROIC
for Fusion Antibodies PLC.

Provide ROCE
for Fusion Antibodies PLC.

Provide Gross Margin
for Fusion Antibodies PLC.

Provide Operating Margin
for Fusion Antibodies PLC.

Provide Net Margin
for Fusion Antibodies PLC.

Provide FCF Margin
for Fusion Antibodies PLC.

Show all solvency ratios
for Fusion Antibodies PLC.

Provide D/E Ratio
for Fusion Antibodies PLC.

Provide D/A Ratio
for Fusion Antibodies PLC.

Provide Interest Coverage Ratio
for Fusion Antibodies PLC.

Provide Altman Z-Score Ratio
for Fusion Antibodies PLC.

Provide Quick Ratio
for Fusion Antibodies PLC.

Provide Current Ratio
for Fusion Antibodies PLC.

Provide Cash Ratio
for Fusion Antibodies PLC.

What is the historical Revenue growth
over the last 5 years for Fusion Antibodies PLC?

What is the historical Net Income growth
over the last 5 years for Fusion Antibodies PLC?

What is the current Free Cash Flow
of Fusion Antibodies PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fusion Antibodies PLC.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

There are no price targets for FAB.

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

Fusion Antibodies PLC Competitors:
Price Targets

301333

R&G PharmaStudies Co Ltd

36% Upside

RVTY

Revvity Inc

39% Upside

688222

HitGen Inc

6% Downside

MEDP

Medpace Holdings Inc

3% Upside

301333

R&G PharmaStudies Co Ltd

36% Upside

RVTY

Revvity Inc

39% Upside

688222

HitGen Inc

6% Downside

MEDP

Medpace Holdings Inc

3% Upside

300404

Boji Medical Technology Co Ltd

35% Upside

GENO

Genovis AB

53% Upside

BANB

Bachem Holding AG

34% Upside

LONN

Lonza Group AG

17% Upside

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

For the last 8 years the compound annual growth rate for Fusion Antibodies PLC's revenue is -3%. The projected CAGR for the next 1 year is 86%.

-3%

Past Growth

86%

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-77%

Average Miss

What are analyst estimates?

What is FAB's stock price target?

Not Available

FAB doesn't have any price targets made by Wall Street professionals.

What is Fusion Antibodies PLC's Revenue forecast?

Projected CAGR
86%

For the last 8 years the compound annual growth rate for Fusion Antibodies PLC's revenue is -3%. The projected CAGR for the next 1 year is 86%.

	Franklin Covey Co NYSE:FC	22.31 USD
	Mohawk Industries Inc NYSE:MHK	101.535 USD 0.74%
	Ardmore Shipping Corp NYSE:ASC	9.49 USD -1.86%
	ASGN Inc NYSE:ASGN	53.18 USD 1.14%
	Skyworks Solutions Inc NASDAQ:SWKS	72.005 USD 1.72%
	Weatherford International PLC NASDAQ:WFRD	48.76 USD 4.12%

	Johnson & Johnson NYSE:JNJ	154.67 USD 0.66%
	Bank of America Corp NYSE:BAC	44.8101 USD 0.97%
	Mastercard Inc NYSE:MA	587.62 USD 0.37%
	Salesforce Inc NYSE:CRM	272.61 USD 2.05%
	Abbvie Inc NYSE:ABBV	190.315 USD 1.52%
	Home Depot Inc NYSE:HD	369.06 USD -0.06%

	Arista Networks Inc NYSE:ANET	96.99 USD 1.9%
	Deckers Outdoor Corp NYSE:DECK	109.6 USD 1.18%
	Visa Inc NYSE:V	369.155 USD 0.65%
	Texas Pacific Land Corp NYSE:TPL	1 133 USD 3.65%
	KLA Corp NASDAQ:KLAC	812.75 USD 2.63%
	Manhattan Associates Inc NASDAQ:MANH	191.9 USD 0.9%

	Salesforce Inc NYSE:CRM	272.61 USD 2.05%
	Accenture PLC NYSE:ACN	318.21 USD 0.9%
	ServiceNow Inc NYSE:NOW	1 030.805 USD 1.3%
	Spotify Technology SA NYSE:SPOT	713.13 USD 0.04%
	Monster Beverage Corp NASDAQ:MNST	63.4 USD 0.63%
	Applied Materials Inc NASDAQ:AMAT	168.87 USD 2.85%

Fusion Antibodies PLC
LSE:FAB

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

See Also

What is FAB's stock price target?

Not Available

What is Fusion Antibodies PLC's Revenue forecast?

Projected CAGR
86%

Company

Help

Tools

Stocks

	Fusion Antibodies PLC LSE:FAB	6.35 GBX -3.79%
	Cintas Corp NASDAQ:CTAS	227.975 USD 0.47%

Fusion Antibodies PLC LSE:FAB

Wall Street Price Targets

FAB Price Targets Summary Fusion Antibodies PLC

Revenue Forecast

Revenue Estimate Fusion Antibodies PLC

Operating Income Forecast

Operating Income Estimate Fusion Antibodies PLC

Net Income Forecast

Net Income Estimate Fusion Antibodies PLC

See Also

What is FAB's stock price target? Not Available

What is Fusion Antibodies PLC's Revenue forecast? Projected CAGR 86%

Company

Help

Tools

Stocks

Fusion Antibodies PLC
LSE:FAB

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

What is FAB's stock price target?

Not Available

What is Fusion Antibodies PLC's Revenue forecast?

Projected CAGR
86%